Accession Number: | 0001209191-21-030629 |
Date: | 2021-05-05 |
Issuer: | ARCA BIOPHARMA, INC. (ABIO) |
Original Submission Date: |
CONWAY ROBERT E
10170 CHURCH RANCH WAY
SUITE 100
WESTMINSTER, CO 80021
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2021-05-05 | P | 10,000 | a | $3.23 | 40,000 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | the price represents the weighted average purchase price for multiple transactions reported on this line. the prices of the transactions ranged from$3.229 to $3.24. upon request of the sec staff, arca biopharma, inc. (the "company") or a security holder of the company, the reporting personwill provide full information regarding the number of shares purchased at each separate price. |